在临床中考虑辉瑞-生物科技公司 COVID-19 疫苗准备工作：质量与数量。
Considerations in Pfizer-BioNTech COVID-19 vaccine preparation in clinic: Quality vs quantity.
机构信息
Therapeutic Development Branch National Center for Advancing Translational Sciences National Institutes of Health Rockville, MD, USA.
Center for Drug Evaluation and Research Food and Drug Administration Silver Spring, MD, USA.
出版信息
Am J Health Syst Pharm. 2022 Feb 18;79(5):325-327. doi: 10.1093/ajhp/zxab388.
In an effort to expedite the publication of articles , AJHP is posting manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time.
为了加快文章的发表速度，AJHP 在接受后尽快将手稿在线发布。已接受的手稿已经经过同行评审和编辑，但在进行技术格式和作者校对之前在线发布。这些手稿不是记录的最终版本，稍后将用最终文章（按照 AJHP 风格格式化并由作者校对）替换。
Zotero 插件